ArticleMicrobial cell factories2026
Enhanced fumarate production using high-density cultivation of Synechocystis sp. PCC 6803.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cyanobacteria are photosynthetic microorganisms that can fix CO2 via the Calvin–Benson–Bassham cycle and store carbon as glycogen, which is subsequently catabolized through multiple pathways. Unicellular cyanobacteria such as Synechocystis sp. PCC 6803 possess a unique tricarboxylic acid (TCA) cycle, lacking 2-oxoglutarate dehydrogenase, and excrete various low-molecular-weight carboxylic acids under dark, anaerobic conditions. Fumarate, which is a TCA cycle metabolite widely used in food additives and bioplastics, has been produced at titers below 120 mg/L in cyanobacteria, thereby limiting its industrial potential. Here, we established high-density cultivation of genetically engineered Synechocystis sp. PCC 6803 and characterized a mutant lacking fumarase (ΔfumC), an enzyme that catalyzes the reversible conversion of fumarate to malate in the TCA cycle. The ΔfumC mutant exhibited increased photosynthetic activity and grew comparably to the wild-type strain under high-density conditions. The ΔfumC strains were cultivated at high density in nutrient-enriched BG-11 media (5 × , 10 × , and 15 ×) under 1% CO2 and 300 μmol photons/m2/s, resulting in fumarate production of up to 1.7 g/L fumarate under these conditions. Furthermore, the combination of fumC knockout with ppc overexpression (encoding phosphoenolpyruvate carboxylase) enabled fumarate production at the highest titer reported to date (> 2 g/L) under photoautotrophic conditions. This study highlights the effectiveness of metabolic engineering combined with cultivation optimization to overcome the intrinsic bottlenecks in cyanobacterial carboxylic acid production, providing a promising platform for sustainable bioproduction from CO2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.